Linezolid: a review of its properties, function, and use in critical care

  title={Linezolid: a review of its properties, function, and use in critical care},
  author={S. R. Hashemian and T. Farhadi and Mojdeh Ganjparvar},
  journal={Drug Design, Development and Therapy},
  pages={1759 - 1767}
  • S. R. Hashemian, T. Farhadi, Mojdeh Ganjparvar
  • Published 2018
  • Medicine
  • Drug Design, Development and Therapy
  • Linezolid can be considered as the first member of the class of oxazolidinone antibiotics. The compound is a synthetic antibiotic that inhibits bacterial protein synthesis through binding to rRNA. It also inhibits the creation of the initiation complex during protein synthesis which can reduce the length of the developed peptide chains, and decrease the rate of reaction of translation elongation. Linezolid has been approved for the treatment of infections caused by vancomycin-resistant… CONTINUE READING
    57 Citations
    Fosfomycin: the characteristics, activity, and use in critical care
    • 3
    • PDF
    Linezolid and Its Immunomodulatory Effect: In Vitro and In Vivo Evidence
    • 3
    • PDF
    Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria
    • Highly Influenced
    • PDF
    Linezolid drug interactions: A retrospective study
    • PDF
    A critical review of HPLC-based analytical methods for quantification of Linezolid
    • 4
    In Silico Designing of Peptidomimetics Enhancing Endoribonucleolytic Activities of Acinetobacter MazF Toxin as the Novel Anti-bacterial Candidates
    • 3


    Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
    • 229
    • PDF
    Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
    • 71
    • PDF
    Structural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome
    • 18
    • PDF
    Linezolid: a review of safety and tolerability.
    • 144
    An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy
    • 45
    • Highly Influential
    • PDF
    Virtual Screening for Potential Inhibitors of CTX-M-15 Protein of Klebsiella pneumoniae
    • 13
    Oxazolidinones: a new class of antibacterials.
    • 74